Caregiver

77% of Employers Plan to Increase Investment in Virtual Health Care, says Teladoc Health’s 2023 Virtual Care Transformation Index

Retrieved on: 
Monday, September 18, 2023

“For employers, the stakes are high when it comes to making sure quality healthcare is always within reach,” said Kelly Bliss, Teladoc Health US Group Health President.

Key Points: 
  • “For employers, the stakes are high when it comes to making sure quality healthcare is always within reach,” said Kelly Bliss, Teladoc Health US Group Health President.
  • “When we first initiated this study, employers were only starting to realize the value and potential of a whole-person virtual care strategy.
  • Employers continue to invest in mental health services: Employers reported mental health and primary care services are the most prevalent virtual services in their benefits strategies and 40% of employers plan to expand their virtual mental health services over the next three years.
  • Employers are embracing vendor integration and a seamless, whole-person approach to care: Nearly 90% of employers said an integrated whole-person virtual care strategy was “very” or “extremely” important.

Easterseals Northern California Expands Services and Debuts New Program Name

Retrieved on: 
Friday, September 22, 2023

Today, Easterseals Northern California (ESNorCal) announced that it has expanded its autism services to encompass a broader range of care available to families across Northern California.

Key Points: 
  • Today, Easterseals Northern California (ESNorCal) announced that it has expanded its autism services to encompass a broader range of care available to families across Northern California.
  • To better reflect these offerings, the organization’s Autism Services Program will be known by a new name: Behavioral Health Services.
  • View the full release here: https://www.businesswire.com/news/home/20230922020539/en/
    Participants from Easterseals Northern California’s adult program, Kaleidoscope, assemble gift bags for the event celebrating the organization’s new program name: Behavioral Health Services.
  • Our new program name, Behavioral Health Services, reflects the broader range of care we now offer.”
    Participants from the ESNorCal adult program, Kaleidoscope, assembled gift bags for attendees of the renaming celebration.

Innate Pharma Announces Encore Presentation of Interim Results of Phase 2 TELLOMAK Study With Lacutamab With Updated Olsen 2022 Criteria at the EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 2023

Retrieved on: 
Friday, September 22, 2023

The data were previously presented at the 17th International Conference on Malignant Lymphoma , in Lugano (Switzerland), in June 2023.

Key Points: 
  • The data were previously presented at the 17th International Conference on Malignant Lymphoma , in Lugano (Switzerland), in June 2023.
  • Lymph Node assessment is an important component of staging and response assessment in CTCL (cutaneous T cell lymphomas).
  • “We are pleased to present the interim results of the Phase 2 TELLOMAK study based on updated guidelines at the EORTC Cutaneous Lymphoma Tumour Group Meeting.
  • The higher global ORR according to updated lymph node further supports the ongoing development of lacutamab in T cell lymphomas.

Manatt Grows Value-Based Care Capabilities With Preeminent Health Care Executive in D.C.

Retrieved on: 
Wednesday, September 20, 2023

Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, today announced the addition of Seth Frazier to the Firm’s Washington, D.C. office as a managing director with Manatt Health.

Key Points: 
  • Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, today announced the addition of Seth Frazier to the Firm’s Washington, D.C. office as a managing director with Manatt Health.
  • At Manatt, he advises a diverse range of stakeholders—including pediatric hospitals, emerging digital health companies, academic medical centers and integrated health systems—on driving strategic transformation and advancing value-based care.
  • “As health care organizations continue to prioritize value-based care, we have been purposely building out our broader capabilities to support providers, payers and other stakeholders drive innovation in this space,” said Manatt Health Leader Bill Bernstein .
  • Frazier has also held chief strategy officer and chief transformation officer roles for multibillion-dollar health systems with integrated health plans, a preeminent children’s hospital and a publicly traded population health infrastructure company.

Five Wishes® and MyDirectives® Are Enhancing the Future of Digital Advance Care Planning

Retrieved on: 
Wednesday, September 20, 2023

Five Wishes and ADVault, Inc. have announced their collaboration to embed the Five Wishes advance care planning (ACP) documents and resources into the revolutionary MyDirectives Solutions™ platform.

Key Points: 
  • Five Wishes and ADVault, Inc. have announced their collaboration to embed the Five Wishes advance care planning (ACP) documents and resources into the revolutionary MyDirectives Solutions™ platform.
  • “Combined with ADVault’s world-class MyDirectives Solutions, the embedding of Five Wishes will allow for a patient-centered approach to advance care planning integrated into the workflows and digital solutions for healthcare professionals.
  • Medical teams, often in emergent care situations, lacked visibility into the completion and content of these paper-based documents.
  • By providing an unrivaled, simple to learn, user-friendly, comprehensive, digital ACP solution, they set an ambitious new standard for accessible advance care planning across the healthcare continuum.

Relias Launches Largest Set of Multi-Language, Online Home-Based Care Education Courses

Retrieved on: 
Tuesday, September 19, 2023

This new offering from Relias is now the largest of its kind.

Key Points: 
  • This new offering from Relias is now the largest of its kind.
  • The caregiver courses span fundamental job training, compliance training, and point-of-care microlearning and have been well-received with more than 17,000 courses completed since launch.
  • “With immigrants accounting for 25% of direct care workers, multilingual courses are necessary for agencies to train their entire organizations and improve caregiver performance and competency.
  • To learn more about Relias’ online home health and home care training courses visit: https://www.relias.com/who-we-serve/home-based-care .

CareDx To Present at the 2023 Cantor Global Healthcare Conference

Retrieved on: 
Tuesday, September 19, 2023

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the 2023 Cantor Global Healthcare Conference.

Key Points: 
  • CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the 2023 Cantor Global Healthcare Conference.
  • CareDx’s management is scheduled to present at the 2023 Cantor Global Healthcare Conference on Wednesday, September 27, 2023, at 7:20 AM PT / 10:20 AM ET.
  • To listen to the webcast, please visit the Events & Presentations section of CareDx’s investor relations website at: investors.caredxinc.com.

Medidata Launches Industry’s Most Comprehensive Program to Support Clinical Trial Diversity Initiatives

Retrieved on: 
Tuesday, September 19, 2023

Medidata , a Dassault Systèmes company, today announced the launch of the Medidata Diversity Program , the industry’s most comprehensive solution for improving diversity, equity, and inclusion in clinical trials.

Key Points: 
  • Medidata , a Dassault Systèmes company, today announced the launch of the Medidata Diversity Program , the industry’s most comprehensive solution for improving diversity, equity, and inclusion in clinical trials.
  • The Medidata Diversity Program supports biopharmaceutical and medical device companies and clinical research organizations (CROs) by addressing common systemic and clinical barriers that can hinder a diverse range of individuals from participating in clinical trials.
  • This landmark launch coincides with increasing dialogue among industry leaders and regulators about the need for greater diversity throughout the clinical trial process.
  • Designed to embed diversity into every aspect of the process, this program positions Medidata as a catalyst for cultivating diversity, closing disparities, and achieving true clinical trial success.

BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA®

Retrieved on: 
Tuesday, September 19, 2023

“We are excited to announce the European Commission approval and the FDA filing acceptance for tislelizumab, having recently regained full global rights to this important medicine.

Key Points: 
  • “We are excited to announce the European Commission approval and the FDA filing acceptance for tislelizumab, having recently regained full global rights to this important medicine.
  • The study enrolled 513 patients from 132 research sites in 11 countries in Europe, Asia and North America.
  • The FDA has assigned a target action date in the second half of 2024, under the Prescription Drug User Fee Act.
  • The FDA also granted tislelizumab Orphan Drug Designation (ODD) for the treatment of previously untreated advanced or metastatic ESCC.

Scene Health & The Research Institute at Nationwide Children’s Hospital Secure $1.9M in NIH Funding to Pursue Improvements in Sickle Cell Disease Care and Outcomes

Retrieved on: 
Tuesday, September 19, 2023

Sickle cell disease hurts, and the debilitating pain can send children to the hospital multiple times a year.

Key Points: 
  • Sickle cell disease hurts, and the debilitating pain can send children to the hospital multiple times a year.
  • Today, Scene Health and the Research Institute at Nationwide Children's Hospital announced a $1.9 million effort to help children and teenagers living with sickle cell disease (SCD) improve their health and quality of life through increased adherence to hydroxyurea treatment.
  • The Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood Institute will fund the ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness) study.
  • With Scene's collaboration, the ADHERE study is poised to optimize video DOT's ability to promote lasting adherence.